Investors have a limited window between September 21 and 25, 2026, to buy shares of five high-yield stocks and qualify for upcoming dividend payments. These include three Gladstone-family monthly payers with a September 21 ex-dividend date, and two others—a cannabis-focused BDC and a Capesize dry-bulk shipper—going ex on September 25. To receive dividends, shares must be purchased before the ex-dividend date; otherwise, the seller retains the payment. Key names include Gladstone Capital, Gladstone Commercial, Gladstone Investment, Chicago Atlantic BDC, and Seanergy Maritime Holdings, each with varying dividend yields and financial health indicators. Investors should act quickly as missing the ex-date means missing the dividend payout.
Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...
Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...
Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
